Sanifit opens a subsidiary in US
Sanifit abre una filial en Estados Unidos
Intel ID : 237472
| Synopsis |
|
Sanifit, a biotech company engaged in research for lime's disease treatments, decided to open a subsidiary in San Diego (United States), as reported by the company through a press release on June 7, 2016. The opening Sanifit in the United States and the appointment of Dr. Preston S. Klassen as its medical director, is part of the company's expansion strategy in US.
(content in spanish)
Sanifit, empresa biotecnológica dedicada a la investigación en tratamientos para problemas de calcificación, ha decidido abrir una filial en San Diego (Estados Unidos), según ha informado la propia compañía en una nota de prensa el 7 de junio de 2016. La apertura de Sanifit EEUU y el nombramiento del doctor Preston S. Klassen como su director médico, se enmarca dentro de la estrategia de la compañía de expandirse por Estados Unidos. |
Relevant Documents
| Press Release | 07 Jun 2016 | Sanifit_Press_Release_2016.pdf | EN |
|
| Intel ID | 237472 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Country |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.